BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

13 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis and biological evaluation of potent FAAH inhibitors.EBI
Univ. Lille
Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitors.EBI
Univ. Lille
Recent advances in Fragment-based strategies against tuberculosis.EBI
Univ. Lille
N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease.EBI
Univ. Lille
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.EBI
Univ. Lille
Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction.EBI
Univ. Lille
Identification of indole-based activators of insulin degrading enzyme.EBI
Univ. Lille
High ligand efficiency quinazoline compounds as novel AEBI
Univ. Lille
Benzo[d]thiazol-2(3H)-ones as new potent selective CBEBI
Univ. Lille
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.EBI
Univ. Lille
Kinetic Target-Guided Synthesis: Reaching the Age of Maturity.EBI
Univ. Lille
Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MTEBI
Univ. Lille
Development of novel oxazolo[5,4-d]pyrimidines as competitive CBEBI
Univ. Lille